trans-AUCB
Cat. No.：YN370785
| 产品名称: | trans-AUCB |
| CAS No.: | 885012-33-9 |
| Chemical Name: | 4-[[trans-4-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]cyclohexyl]oxy]-benzoic acid |
| Synonyms: | t-AUCB |
| 分子量: | 412.52 |
| 分子式: | C₂₄H₃₂N₂O₄ |
| SMILES: | OC(C(C=C1)=CC=C1O[C@@H](CC2)CC[C@H]2NC(NC34C[C@H](C5)C[C@H](C[C@H]5C4)C3)=O)=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | trans-AUCB (t-AUCB) 是一种有效的，具有口服活性和选择性的可溶性环氧水解酶 (sEH) 抑制剂，对 人，小鼠和大鼠的 sEH 的IC50分别为 1.3 nM，8 nM，8 nM。trans-AUCB 具有抗神经胶质瘤活性。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Schmelzer, K.R., Kubala, L., Newman, J.W., et al.Soluble epoxide hydrolase is a therapeutic target for acute inflammationProc. Natl. Acad. Sci. USA102(28),9772-9777(2005)
Yu, Z., Xu, F., Huse, L.M., et al.Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acidsCirc. Res.87(11),992-998(2000)
Hwang, S.H., Wagner, K.M., Morisseau, C., et al.Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolaseJ. Med. Chem.54(8),3037-3050(2011)
Tsai, H.J., Hwang, S.H., Morisseau, C., et al.Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogsEur. J. Pharm. Sci.40(3),222-238(2010)
Imig, J.D., and Hammock, B.D.Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesNat. Rev. Drug Discov.8(10),794-805(2009)
Zhang, G., Panigrahy, D., Hwang, S.H., et al.Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasisProc. Natl. Acad. Sci. USA111(30),11127-11132(2014)
